文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

PIWIL1 调控肝癌中肿瘤细胞代谢与免疫抑制微环境的串扰。

PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.

机构信息

School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People's Republic of China.

School of Life Sciences, Jilin University, Changchun City, Jilin Province, People's Republic of China.

出版信息

Signal Transduct Target Ther. 2021 Feb 26;6(1):86. doi: 10.1038/s41392-021-00485-8.


DOI:10.1038/s41392-021-00485-8
PMID:33633112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907082/
Abstract

Altered energy metabolism of cancer cells shapes the immune cell response in the tumor microenvironment that facilitates tumor progression. Herein, we reported the novel of tumor cell-expressed Piwi Like RNA-Mediated Gene Silencing 1 (PIWIL1) in mediating the crosstalk of fatty acid metabolism and immune response of human hepatocellular carcinoma (HCC). PIWIL1 expression in HCC was increased compared to normal hepatic tissues and was positively correlated with the proliferation rate of HCC cell lines. PIWIL1 overexpression accelerated in vitro proliferation and in vivo growth of HCC tumors, while PIWIL1 knockdown showed opposite effects. PIWIL1 increased oxygen consumption and energy production via fatty acid metabolism without altering aerobic glycolysis. Inhibition of fatty acid metabolism abolished PIWIL1-induced HCC proliferation and growth. RNA-seq analysis revealed that immune system regulation might be involved, which was echoed by the experimental observation that PIWIL1-overexpressing HCC cells attracted myeloid-derived suppressor cells (MDSCs) into the tumor microenvironment. MDSCs depletion reduced the proliferation and growth of PIWIL1-overexpressing HCC tumors. Complement C3, whose secretion was induced by PIWIL1 in HCC cells, mediates the interaction of HCC cells with MDSCs by activated p38 MAPK signaling in MDSCs, which in turn initiated expression of immunosuppressive cytokine IL10. Neutralizing IL10 secretion reduced the immunosuppressive activity of MDSCs in the microenvironment of PIWIL1-overexpressing HCC. Taken together, our study unraveled the critical role of PIWIL1 in initiating the interaction of cancer cell metabolism and immune cell response in HCC. Tumor cells-expressed PIWIL1 may be a potential target for the development of novel HCC treatment.

摘要

癌细胞能量代谢的改变塑造了肿瘤微环境中免疫细胞的反应,从而促进了肿瘤的进展。在此,我们报道了肿瘤细胞表达的 Piwi 样 RNA 介导基因沉默 1(PIWIL1)在介导脂肪酸代谢和人肝细胞癌(HCC)免疫反应的串扰中的新作用。与正常肝组织相比,PIWIL1 在 HCC 中的表达增加,并且与 HCC 细胞系的增殖率呈正相关。PIWIL1 过表达加速了 HCC 肿瘤的体外增殖和体内生长,而 PIWIL1 敲低则显示出相反的效果。PIWIL1 通过脂肪酸代谢增加氧消耗和能量产生,而不改变有氧糖酵解。抑制脂肪酸代谢消除了 PIWIL1 诱导的 HCC 增殖和生长。RNA-seq 分析显示免疫系统调节可能涉及其中,这与实验观察结果相呼应,即 PIWIL1 过表达的 HCC 细胞吸引髓源性抑制细胞(MDSC)进入肿瘤微环境。MDSC 耗竭减少了 PIWIL1 过表达 HCC 肿瘤的增殖和生长。补体 C3 的分泌被 HCC 细胞中的 PIWIL1 诱导,通过 MDSC 中激活的 p38 MAPK 信号介导 HCC 细胞与 MDSC 的相互作用,进而引发免疫抑制细胞因子 IL10 的表达。中和 IL10 的分泌减少了 PIWIL1 过表达 HCC 微环境中 MDSC 的免疫抑制活性。总之,我们的研究揭示了 PIWIL1 在启动 HCC 中癌细胞代谢和免疫细胞反应相互作用中的关键作用。肿瘤细胞表达的 PIWIL1 可能是开发新型 HCC 治疗方法的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/c23afd4e68a2/41392_2021_485_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/658223c7292c/41392_2021_485_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/b9a1c46dd436/41392_2021_485_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/9c91681d1074/41392_2021_485_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/1cfe49878e86/41392_2021_485_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/7454850fd6cc/41392_2021_485_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/70f306d18ee3/41392_2021_485_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/c23afd4e68a2/41392_2021_485_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/658223c7292c/41392_2021_485_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/b9a1c46dd436/41392_2021_485_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/9c91681d1074/41392_2021_485_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/1cfe49878e86/41392_2021_485_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/7454850fd6cc/41392_2021_485_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/70f306d18ee3/41392_2021_485_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd44/7907082/c23afd4e68a2/41392_2021_485_Fig7_HTML.jpg

相似文献

[1]
PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.

Signal Transduct Target Ther. 2021-2-26

[2]
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.

J Hepatol. 2018-11-9

[3]
DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC.

Cell Mol Gastroenterol Hepatol. 2024

[4]
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.

Gut. 2017-9-22

[5]
Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.

Oncogene. 2017-2-23

[6]
Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer.

Exp Cell Res. 2017-2-15

[7]
Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.

Cancer Immunol Immunother. 2020-1-21

[8]
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.

Mol Cancer. 2019-2-19

[9]
Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma.

Cancer Med. 2023-8

[10]
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.

Gut. 2019-5-10

引用本文的文献

[1]
Knockdown of LINC00467 inhibits gastric cancer progression by modulating the sequestration of miR-141-3p.

Oncol Lett. 2025-7-24

[2]
piRNA-Mediated Maintenance of Genome Stability in Gametogenesis and Cancer.

Genes (Basel). 2025-6-20

[3]
From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapy.

BMC Cancer. 2025-5-19

[4]
Integration of multi-omics data to unveil the molecular landscape and role of piRNAs in early-onset colorectal cancer.

BMC Med. 2025-4-29

[5]
A novel nomogram based on complement C3 to predict the overall survival of early-stage hepatocellular carcinoma patients with microvascular invasion-positive undergoing curative resection.

Front Oncol. 2025-2-20

[6]
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma.

Discov Oncol. 2025-2-5

[7]
β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion.

Front Immunol. 2025-1-3

[8]
Mechanisms Behind the Impact of PIWI Proteins on Cancer Cells: Literature Review.

Int J Mol Sci. 2024-11-14

[9]
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.

Signal Transduct Target Ther. 2024-10-9

[10]
HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.

Asian Pac J Cancer Prev. 2024-6-1

本文引用的文献

[1]
STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma.

Theranostics. 2020

[2]
Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.

Cancer Immunol Immunother. 2020-5-9

[3]
High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression.

Int J Mol Sci. 2020-3-7

[4]
RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis.

Cancer Immunol Res. 2020-5

[5]
Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3.

Onco Targets Ther. 2020-2-18

[6]
Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy.

Hepatology. 2020-12

[7]
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.

J Exp Med. 2020-2-3

[8]
A Translation-Activating Function of MIWI/piRNA during Mouse Spermiogenesis.

Cell. 2019-12-12

[9]
Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma.

Cancer Immunol Immunother. 2019-10-23

[10]
Metabolic crosstalk in the breast cancer microenvironment.

Eur J Cancer. 2019-9-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索